Search results
1 lut 2017 · Per Cotton et al, 32 the diagnosis of PEP is defined as the presence of pancreatitis (new pancreatic-type abdominal pain accompanied by at least a threefold increase in the serum amylase level) that has developed de novo 24 hours after ERCP.
Frequency and severity of post-ERCP pancreatitis correlated with extent of pancreatic ductal opacification
This review article addresses the underlying mechanisms at play for the development of PEP, identifying patient and procedural risk factors and meaningful use of risk-stratification information, and details current interventions aimed at reducing the risk of this complication. Copyright © 2016 Mayo Foundation for Medical Education and Research.
13 wrz 2024 · Endoscopic retrograde cholangiopancreatography (ERCP) is a specialized endoscopic procedure for managing pancreaticobiliary disorders (eg, removal of bile duct stones, relief of biliary obstruction). The most frequent adverse event associated with ERCP is acute pancreatitis.
8 sie 2022 · A diagnosis of post-ERCP pancreatitis was made if the patients had pancreatic-type abdominal pain (epigastric pain radiating to the back), tenderness that required analgesia and lasted for at least 24 hours after the procedure, and a serum amylase level at least 3 times the normal upper limit.
When ERCP is pursued, prolonged stent therapy (6–12 months) is effective for treating symptoms and remodeling main pancreatic duct strictures. The preferred approach is to place and sequentially add multiple plastic stents in parallel (upsizing); emerging evidence suggests that fully covered self-expanding metal stents may have a role for ...
ERCP enables minimally invasive treatment of a wide range of pancreaticobiliary conditions with substantially lower morbidity than traditional operative approaches. 1-3 The most feared adverse event (AE) of ERCP is post-ERCP pancreatitis (PEP), which occurs in approximately 8% of average-risk and 15% of high-risk procedures and is the most ...
